G. Yu. Usanova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
G. Yu. Usanova has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Dh. G. Uzunyan
S. Fyodorov Eye Microsurgery Federal State Institution
1 shared publication- Ekaterina O. Krasnova
S. Fyodorov Eye Microsurgery Federal State Institution
1 shared publication O. P. Antonova
S. Fyodorov Eye Microsurgery Federal State Institution
1 shared publication- T. M. Baytokova
Inter-industry Scientific Technical Complex "Eye Microsurgery" named after academician S.N. Fedorov
1 shared publication - Tatyana V. Sokolovskaya
S. Fyodorov Eye Microsurgery Federal State Institution
1 shared publication
Latest Publications
- Open Access
- 28 December 2025
- Published by PE Polunina Elizareta Gennadievna in Ophthalmology in Russia
- Vol. 22 (4) , 764-770
Angle-closure Glaucoma Due to Ciliary Body Cysts and Ppseudoplateau Iris: A Systematic Review of the Literature and Clinical Case
The article is a review of domestic and foreign literature devoted to the problem of angle-closure glaucoma (ACG) associated with pseudoplateau iris due to multiple iridociliary cysts, in addition, diagnostic and treatment methods were considered. The analysis of 46 sources on current nosology was carried out on the basis of data from domestic and foreign literature. Timely clinical examination and detection of a high index of suspicion in patients with an atypical structure of narrow or closed corners of the anterior chamber, especially in young patients without previous trauma or surgery, to identify ciliary body cysts is necessary. Based on the pathogenetic mechanisms of the disease, it is natural to make the statement, that laser iridectomy in most cases does not lead to the opening of the anterior chamber angle and cannot be recommended as the therapy of choice. According to published sources, there is currently no consensus on the most effective and safe treatment methods, and the therapy of choice for these patients is a wide range of interventions, including medication, laser and surgical treatment, depending on the extent of damage to the ciliary body by cysts and the stage of the disease. According to the literature data, we were unable to find recommendations for the prevention of the development of angle-closure glaucoma on the background of high risk and predictors of this disease. We present a clinical case of genetic bilateral ophthalmohypertension caused by bilateral multiple cysts of iridociliary processes. Changes in ultrasound parameters of biomicroscopy of the anterior segment of the eye and clinical observations after refractive lancetectomy suggest, that timely surgical intervention can improve the quality of life and reduce the risk of glaucoma in this category of patients. Longer observation periods are required for final conclusions.
- 28 December 2025
- Published by PE Polunina Elizareta Gennadievna in Ophthalmology in Russia
- Vol. 22 (4) , 764-770
Open AccessAngle-closure Glaucoma Due to Ciliary Body Cysts and Ppseudoplateau Iris: A Systematic Review of the Literature and Clinical Case
The article is a review of domestic and foreign literature devoted to the problem of angle-closure glaucoma (ACG) associated with pseudoplateau iris due to multiple iridociliary cysts, in addition, diagnostic and treatment methods were considered. The analysis of 46 sources on current nosology was carried out on the basis of data from domestic and foreign literature. Timely clinical examination and detection of a high index of suspicion in patients with an atypical structure of narrow or closed corners of the anterior chamber, especially in young patients without previous trauma or surgery, to identify ciliary body cysts is necessary. Based on the pathogenetic mechanisms of the disease, it is natural to make the statement, that laser iridectomy in most cases does not lead to the opening of the anterior chamber angle and cannot be recommended as the therapy of choice. According to published sources, there is currently no consensus on the most effective and safe treatment methods, and the therapy of choice for these patients is a wide range of interventions, including medication, laser and surgical treatment, depending on the extent of damage to the ciliary body by cysts and the stage of the disease. According to the literature data, we were unable to find recommendations for the prevention of the development of angle-closure glaucoma on the background of high risk and predictors of this disease. We present a clinical case of genetic bilateral ophthalmohypertension caused by bilateral multiple cysts of iridociliary processes. Changes in ultrasound parameters of biomicroscopy of the anterior segment of the eye and clinical observations after refractive lancetectomy suggest, that timely surgical intervention can improve the quality of life and reduce the risk of glaucoma in this category of patients. Longer observation periods are required for final conclusions.
- Open Access
- 27 March 2024
- Published by Skobelkin State Scientific Center of Laser Medicine in Laser Medicine
- Vol. 27 (3) , 36-39
The effectiveness of combined laser treatment technology in patients with glaucoma
Purpose: to study the effectiveness of combined laser treatment in patients with the advanced primary open-angle glaucoma (POAG).Material and methods: the present study included 63 patients with POAG. They were divided into the studied group (32 eyes) and control group (31 eye). Patients age ranged from 65 to 78 years (mean 70.68 ± 4.39 years in the studied group and 69.48 ± 3.82 in the control group). Intraocular pressure (IOP) in all patients was compensated with antihypertensive drops, and in average was 20.36 ± 1.27 mm Hg in the studied group and 20.02 ± 1.43 mm Hg in the control group. The number of antihypertensive drugs used before surgery ranged from 2 to 3 (average 2.40 ± 0.49 in the studied group and 2.51 ± 0.50 in the control group). YAG-LAT was performed with Lightlas YAG Nd-YAG laser (Lightmed, USA). Microimpulse transcleral cyclophotocoagulation (mTS-CPC) was performed with Cyclo G6 Glaucoma Laser System (IRIDEX, USA). In the studied group, all patients had YAG-LAT with mTS-CPC; in the control group – mTS-CPC. Patients were examined on days 1 and 7; and then in 1, 3 and 6 months after the treatment. The obtained results were summarized in a table and were statistically processed.Results: in the studied group, on day 1 after the intervention IOP was (mm Hg): 19.36 ± 1.36, in the control group – 19.45 ± 1.15; on day 7: studied group – 20.59 ± 1.5, control group – 19.9 ± 2.68; in one month: studied group – 13.95 ± 1.67, control group – 15.8 ± 1.5; in three months: studied group – 15.04 ± 1.13, control group – 16.48 ± 1.12; in 6 months: studied group – 15.27 ± 1.77, control group – 16.23 ± 1.41.Conclusion: the combined laser technology which includes YAG-laser activation of the trabecula and mTS-CPC is an effective and safe method for lowering intraocular pressure in patients with glaucoma
- 27 March 2024
- Published by Skobelkin State Scientific Center of Laser Medicine in Laser Medicine
- Vol. 27 (3) , 36-39
Open AccessThe effectiveness of combined laser treatment technology in patients with glaucoma
Purpose: to study the effectiveness of combined laser treatment in patients with the advanced primary open-angle glaucoma (POAG).Material and methods: the present study included 63 patients with POAG. They were divided into the studied group (32 eyes) and control group (31 eye). Patients age ranged from 65 to 78 years (mean 70.68 ± 4.39 years in the studied group and 69.48 ± 3.82 in the control group). Intraocular pressure (IOP) in all patients was compensated with antihypertensive drops, and in average was 20.36 ± 1.27 mm Hg in the studied group and 20.02 ± 1.43 mm Hg in the control group. The number of antihypertensive drugs used before surgery ranged from 2 to 3 (average 2.40 ± 0.49 in the studied group and 2.51 ± 0.50 in the control group). YAG-LAT was performed with Lightlas YAG Nd-YAG laser (Lightmed, USA). Microimpulse transcleral cyclophotocoagulation (mTS-CPC) was performed with Cyclo G6 Glaucoma Laser System (IRIDEX, USA). In the studied group, all patients had YAG-LAT with mTS-CPC; in the control group – mTS-CPC. Patients were examined on days 1 and 7; and then in 1, 3 and 6 months after the treatment. The obtained results were summarized in a table and were statistically processed.Results: in the studied group, on day 1 after the intervention IOP was (mm Hg): 19.36 ± 1.36, in the control group – 19.45 ± 1.15; on day 7: studied group – 20.59 ± 1.5, control group – 19.9 ± 2.68; in one month: studied group – 13.95 ± 1.67, control group – 15.8 ± 1.5; in three months: studied group – 15.04 ± 1.13, control group – 16.48 ± 1.12; in 6 months: studied group – 15.27 ± 1.77, control group – 16.23 ± 1.41.Conclusion: the combined laser technology which includes YAG-laser activation of the trabecula and mTS-CPC is an effective and safe method for lowering intraocular pressure in patients with glaucoma